A new cervical cancer treatment is showing promise in boosting survival rates and reducing recurrence What this breakthrough means for patients.

The following is a summary of "Oncological outcomes after vaginal and robotic-assisted radical trachelectomy in patients with cervical cancer - A single-center prospective cohort study," published in ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Cervical cancer is caused by human papillomavirus HPV and has become a major health concern Read this article to know ...

Joining a clinical trial for cervical cancer opens the door to new treatments that could have life-changing effects.

A mom who was diagnosed with stage four cervical cancer claims doctors said her blood clot symptoms were “just your period.” ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Regeneron UK Limited has announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo (cemiplimab) for use on ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...